A share price of Legend Biotech Corp ADR [LEGN] is currently trading at $23.6, up 2.48%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LEGN shares have gain 9.72% over the last week, with a monthly amount drifted -1.17%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Legend Biotech Corp ADR [NASDAQ: LEGN] stock has seen the most recent analyst activity on January 07, 2026, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $75. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on October 07, 2025, and set its price target to $40. On October 08, 2024, Redburn Atlantic initiated with a Buy rating and assigned a price target of $86 on the stock. Truist started tracking the stock assigning a Buy rating and suggested a price target of $88 on June 17, 2024. H.C. Wainwright reiterated its recommendation of a Buy and reduced its price target to $73 on May 24, 2024. Deutsche Bank started tracking with a Buy rating for this stock on May 23, 2024, and assigned it a price target of $60. In a note dated April 17, 2024, Scotiabank upgraded an Sector Outperform rating on this stock but restated the target price of $65.
Legend Biotech Corp ADR experienced fluctuations in its stock price throughout the past year between $20.21 and $45.30. Currently, Wall Street analysts expect the stock to reach $63.5 within the next 12 months. Legend Biotech Corp ADR [NASDAQ: LEGN] shares were valued at $23.6 at the most recent close of the market. An investor can expect a potential return of 169.07% based on the average LEGN price forecast.
Analyzing the LEGN fundamentals
Trailing Twelve Months sales for Legend Biotech Corp ADR [NASDAQ:LEGN] were 909.83M which represents 70.21% growth. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.27%, Pretax Profit Margin comes in at -0.38%, and Net Profit Margin reading is -0.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.31 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Legend Biotech Corp ADR [NASDAQ:LEGN] is 2.86. In addition, the Quick Ratio stands at 2.80 and the Cash Ratio stands at 1.0. Considering the valuation of this stock, the price to sales ratio is 4.79, the price to book ratio is 4.31.
Transactions by insiders
Recent insider trading involved Huang Ying, Officer, that happened on Dec 26 ’25 when 64339.0 shares were purchased. Director, Sanders Corazon (Corsee) D. completed a deal on Dec 24 ’25 to buy 969.0 shares. Meanwhile, Officer Huang Ying bought 61467.0 shares on Dec 24 ’25.
